ClinicalTrialsFinder
Not Yet RecruitingPhase 2ACTRN12609000098235

Do green tea polyphenols decrease hormone and mammographic density in healthy women

A pilot randomised controlled trial to evaluate the effects of Green Tea Polyphenols on Serum Hormone Levels in healthy women

Sponsor

The University of Western Australia

Enrollment

200 participants

Start Date

Mar 1, 2009

Study Type

Interventional

Conditions

The prevention of Breast cancer

Summary

a 24-week intervention using encapsulated green tea polyphenols to investigate whether or not green tea polyphenols decrease serum hormone concentration and mammographic density in healthy women

Eligibility

Sex: FemalesMin Age: 18 YearssMax Age: 70 Yearss

Plain Language Summary

Simplified for easier understanding

This study investigates whether green tea supplements can lower certain hormone levels and reduce breast density, which is a risk factor for breast cancer. It is for healthy women aged 18 to 70 attending an outpatient breast clinic. Participation involves taking the green tea supplement and having mammograms and blood tests.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Green Tea Polyphenols capsule 700mg oral administration, twice per day with morning and evening meals for 24 weeks Water soluble, decaffeinated green tea extract containing ‘Tea Polyphenols with (–)

Green Tea Polyphenols capsule 700mg oral administration, twice per day with morning and evening meals for 24 weeks Water soluble, decaffeinated green tea extract containing ‘Tea Polyphenols with (–)-epigallocatechin-3-gallate (EGCG) 65% and over’

Locations(1)

Zhejiang Province, China

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12609000098235